Home > Healthcare > Pharmaceuticals > Finished Drug Form > Aesthetic Injectables Market

Aesthetic Injectables Market Share

Report ID: GMI8040
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Aesthetic Injectables Market Share

The aesthetic injectables industry is dynamic and competitive, driven by a combination of innovation, strategic collaborations, global expansion efforts, and a commitment to regulatory compliance. Companies such as Allergan (now part of AbbVie), Galderma, and Merz Pharma are notable players, with well-established product portfolios that include popular dermal fillers and botulinum toxin products.

Aesthetic Injectables Market Companies

Prominent players operating in the aesthetic injectables industry include:

AbbVie Inc (Allergan Plc.)
Bio-Med Private Limited
Bioxis Pharmaceuticals
Cytophil, Inc.
Galderma S.A.
Ipsen SA
Laboratories Vivacy SAS
Merz Pharma GmbH & Co. KGaA.
Mesoestetic
Sinclair Pharma (Huadong Medicine Co., Ltd)
Suneva Medical, Inc
Teoxane Laboratories

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for aesthetic injectables was valued at USD 13.2 billion in 2023 and is anticipated to showcase 10.2% CAGR through 2032 owing to the increasing aging population seeking non-surgical solutions for signs of aging, and rising beauty consciousness across age groups.

The botulinum toxin segment is expected to reach USD 16.8 billion by 2032 owing to its high effectiveness in address dynamic wrinkles and fine lines of facial expressions.

North America market for aesthetic injectables accounted for USD 7.5 billion in 2023 and is projected to reach USD 16.5 billion by 2032 attributed to the well-established and advanced healthcare infrastructure, including numerous dermatology clinics, medical spas, and aesthetic centers.

Who are the key players in the global aesthetic injectables industry?